Abstract:Accurate fluorescence imaging of nanocarriers in vivo remains a challenge owing to interference derived mainly from biological tissues and free probes. To address both issues, the current study explored fluorophores in the near-infrared (NIR)-II window with aggregation-caused quenching (ACQ) properties to improve imaging accuracy. Candidate fluorophores with NIR-II emission, ACQ984 (λem = 984 nm) and IR-1060 (λem = 1060 nm), from the aza-BODIPY and cyanine families, respectively, were compared with the commercial fluorophore ICG with NIR-II tail emission and the NIR-I fluorophore P2 from the aza-BODIPY family. ACQ984 demonstrates high water sensitivity with complete fluorescence quenching at a water fraction greater than 50%. Physically embedding the fluorophores illuminates various nanocarriers, while free fluorophores cause negligible interference owing to the ACQ effect. Imaging based on ACQ984 revealed fine structures in the vascular system at high resolution. Moreover, good in vivo and ex vivo correlations in the monitoring of blood nanocarriers can be established, enabling real-time noninvasive in situ investigation of blood pharmacokinetics and dynamic distribution in various tissues. IR-1060 also has a good ACQ effect, but the lack of sufficient photostability and steady post-labeling fluorescence undermines its potential for nanocarrier bioimaging. P2 has an excellent ACQ effect, but its NIR-I emission only provides nondiscriminative ambiguous images. The failure of the non-ACQ probe ICG to display the biodistribution details serves as counterevidence for the improved imaging accuracy by NIR-II ACQ probes. Taken together, it is concluded that fluorescence imaging of nanocarriers based on NIR-II ACQ probes enables accurate in vivo bioimaging and real-time in situ pharmacokinetic analysis.

Selection of an aggregation-caused quenching-based fluorescent tracer for imaging studies in nano drug delivery systems

New Progress in Aza-BODIPY-based Fluorescence Probes

Near‐infrared Fluorophores with Absolute Aggregation‐caused Quenching and Negligible Fluorescence Re‐illumination for in Vivo Bioimaging of Nanocarriers

Photostable Fluorescent Organic Dots with Aggregation-Induced Emission (aie Dots) for Noninvasive Long-Term Cell Tracing

Julolidinyl Aza-Bodipys As NIR-II Fluorophores for the Bioimaging of Nanocarriers

In vivo fluorescence imaging of nanocarriers in near-infrared window II based on aggregation-caused quenching

Aggregation-induced red-NIR emission organic nanoparticles as effective and photostable fluorescent probes for bioimaging

Biocompatible organic dots with aggregation-induced emission for in vitro and in vivo fluorescence imaging

Environment-responsive Aza-Bodipy Dyes Quenching in Water As Potential Probes to Visualize the in Vivo Fate of Lipid-Based Nanocarriers.

Towards more accurate bioimaging of drug nanocarriers: turning aggregation-caused quenching into a useful tool.

Ultrafast and Noninvasive Long-Term Bioimaging with Highly Stable Red Aggregation-Induced Emission Nanoparticles

Near-Infrared Fluorescent 4,4-Difluoro-4-bora-3a,4a-diaza-s-indacene Probes for One- and Two-Photon Fluorescence Bioimaging

Implications of Quenching‐to‐Dequenching Switch in Quantitative Cell Uptake and Biodistribution of Dye‐Labeled Nanoparticles

Photoactivatable Aggregation-Induced Emission Probes for Lipid Droplets-Specific Live Cell Imaging

Real-time Near-infrared Fluorescent Reporting the Azoreductase-triggered Drug Release

Near-infrared fluorescent probe for tracing diquat in aqueous solutions and bioimaging in vivo

Quaternary Ammonium Salt Based NIR‐II Probes for In Vivo Imaging

Rational Design of Cyanovinyl-Pyrene Dual-Emission AIEgens for Potential Application in Dual-Channel Imaging and Ratiometric Sensing in Living Cells

An easily accessible aggregation-induced emission probe for lipid droplet-specific imaging and movement tracking.

Improving Quantum Yield of a NIR‐II Dye by Phenylazo Group

Quantum dot-based nanoprobes for in vivo targeted imaging.